LAS VEGAS, June 7, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX), a biotechnology and research company, today announced through its local partnership, GB Sciences Nevada, LLC, that it has secured a special use permit in Clark County, Nevada for its medical marijuana establishment. The Company completed its presentation to the Board of Commissioners and was successful in acquiring this special use permit for its Fort Apache dispensary. The Company will await final State approval and will be applying for a State business license in the coming weeks.
Clark County held three days of lengthy public hearings in order for applicants to present to the commission. Commissioners allowed the public time and access for rebuttals in their respective neighborhoods, and voted on the third day, after a full review of all presentations. A list of required information was set in ordinance and applicants were required to meet each and all ordinances. The Company met all ordinances and will move forward in applying to the State for a business license to operate its dispensary.
GrowBLOX Sciences, CEO, Craig Ellins said, "The Company is extremely excited to move forward in its Nevada initiatives and we are pleased to have secured a special use permit from Clark County. Clark County Commissioners conducted a thorough process in vetting all applications. A lot of man-hours were put in and they did a wonderful job. Our Fort Apache location will bring much needed relief to local patients and will have a positive impact on the community. I am happy to say this is a good day for GrowBLOX, and a great day for patients and the State of Nevada."
The partnership was one of 81 applicants for dispensaries in Clark County and out of that 81, 18 were chosen for the special use permit license. The Company's Fort Apache location is the only dispensary to service the needs of patients in that area, making The Company special use permit license all the more important for Clark County.
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Riverview Capital Enterprises
SOURCE GrowBLOX Sciences, Inc.